Sampa Biswas

588 citations
31 papers · 418 indexed · h-index 10
Topics
Enzyme Production and Characterization (14 papers)Biochemical and Structural Characterization (10 papers)Peptidase Inhibition and Analysis (10 papers)

In The Last Decade

Sampa Biswas

30 papers receiving 406 citations

Peers

Sampa Biswas
Comparison fields: 5 of 79
  • Molecular Biology 253
  • Infectious Diseases 134
  • Biotechnology 93
  • Oncology 65
  • Plant Science 38
Replace Tsu‐An Hsu with:
Tsu‐An Hsu Taiwan
Michael Petukhov Russia
John E. Hanson United States
Carina M. C. Lobley United Kingdom
E. Bettler France
Debanu Das United States
Louise Thauvette Canada
Erandi Lira‐Navarrete Spain
Linghang Peng United States
Sampa Biswas relative to Tsu‐An Hsu Taiwan Tsu‐An Hsu's profile →
Citations per field
00.5×1.5×1.9×
Tsu‐An Hsu · 1×
Citations per year

Countries citing papers authored by Sampa Biswas

Since Specialization
Citations

This map shows the geographic impact of Sampa Biswas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sampa Biswas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sampa Biswas more than expected).

Fields of papers citing papers by Sampa Biswas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sampa Biswas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sampa Biswas. The network helps show where Sampa Biswas may publish in the future.

Co-authorship network of co-authors of Sampa Biswas

This figure shows the co-authorship network connecting the top 25 collaborators of Sampa Biswas. A scholar is included among the top collaborators of Sampa Biswas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sampa Biswas. Sampa Biswas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 7
4 1
5 7
6 5
7 7
8 10
9 9
10 20
11 5
12 31
13 6
14 21
15 12
16 18
17 2
18 6
19 19
20 4

About Sampa Biswas

Sampa Biswas is a scholar working on Biotechnology, Oncology and Molecular Biology, having authored 31 papers that have together received 418 indexed citations. Recurring topics across this work include Enzyme Production and Characterization (14 papers), Biochemical and Structural Characterization (10 papers) and Peptidase Inhibition and Analysis (10 papers). The work is most often cited by research in Biotechnology (93 citations), Infectious Diseases (134 citations) and Molecular Biology (253 citations). Sampa Biswas has collaborated with scholars based in India, South Korea and United States. Frequent co-authors include Raghunath Chatterjee, Sayantan Laha, Soumen Manna, Joyeeta Chakraborty, Chandana Chakrabarti, J. Κ. Dattagupta, Medicherla V. Jagannadham, Pulakesh Aich, Mousumi Banerjee and Samita Basu. Their work appears in journals such as PLoS ONE, Biochemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026